Impaired natural killer activity and expression of interleukin-2 receptor antigen in familial erythrophagocytic lymphohistiocytosis
Data up to Jan 2025
Total Citations Per Year
Abstract
References (27)
Glucocorticoid-induced inhibition of T cell growth factor production. I. The effect on mitogen-induced lymphocyte proliferation.
1979 • 567 citations
Familial hemophagocytic lymphohistiocytosis
1983 • 567 citations
Human natural killer cells: biologic and pathologic aspects.
1984 • 419 citations
TCGF (IL 2)-receptor inducing factor(s). I. Regulation of IL 2 receptor on a natural killer-like cell line (YT cells).
1985 • 373 citations
Interleukin 2 binding molecule distinct from the Tac protein: analysis of its role in formation of high-affinity receptors.
1987 • 252 citations
The p75 peptide is the receptor for interleukin 2 expressed on large granular lymphocytes and is responsible for the interleukin 2 activation of these cells.
1987 • 226 citations
Differentiation stages of human natural killer cells in lymphoid tissues from fetal to adult life.
1983 • 184 citations
Successful treatment of lymphohistiocytic reticulosis with phagocytosis with epipodophyllotoxin VP 16–213
1980 • 180 citations
Allogeneic bone marrow transplantation for erythrophagocytic lymphohistiocytosis
1986 • 164 citations
Epstein-Barr virus-associated hemophagocytic syndrome: virological and immunopathological studies
1985 • 146 citations
X-linked lymphoproliferative syndrome. Natural history of the immunodeficiency.
1983 • 129 citations
Impaired natural killer activity in lymphohistiocytosis syndrome
1984 • 126 citations
Natural killer (HNK-1+) cells in Chediak-Higashi patients are present in normal numbers but are abnormal in function and morphology.
1982 • 99 citations
Interleukin 2 enhances the natural killer cell activity of acquired immunodeficiency syndrome patients through a gamma-interferon-independent mechanism.
1985 • 86 citations
Distribution of lymphocytes with interleukin-2 receptors (TAC antigens) in reactive lymphoproliferative processes, Hodgkin's disease, and non-Hodgkin's lymphomas. An immunohistologic study of 300 cases.
1987 • 85 citations
Immunologic and clinical effects of repeated blood exchange in familial erythrophagocytic lymphohistiocytosis
1982 • 56 citations
Immunologic dysregulation in a patient with familial hemophagocytic lymphohistiocytosis
1987 • 39 citations
Natural killer‐interferon system in patients with preleukaemic states
1984 • 39 citations
Hemophagocytic reticulosisA case report with investigations of immune and white cell function
1975 • 37 citations
Peripheral blood lymphocytes from patients with cancer lack interleukin-2 receptors
1988 • 30 citations
Familial erythrophagocytic lymphohistiocytosis: An association with serum lipid abnormalities
1983 • 28 citations
Mitogenicity and down-regulation of high-affinity interleukin 2 receptor by YTA-1 and YTA-2, monoclonal antibodies that recognize 75-kDa molecules on human large granular lymphocytes.
1989 • 26 citations
Use of VP-16–213 in the treatment of familial erythrophagocytic lymphohistiocytosis
1986 • 24 citations
Abnormalities of interleukin 2 receptor expression associated with decreased antigen-induced lymphocyte proliferation in patients with AIDS and related disorders.
1987 • 21 citations
Endoperoxidation, hyperprostaglandinemia, and hyperlipidemia in a case of erythrophagocytic lymphohistiocytosis. Reversal with VP-16 and indomethacin
1987 • 19 citations
Expression of CD 25 (Tac antigen) in lymphoid leukemias and non‐Hodgkin lymphomas
1987 • 13 citations
Reversible graft versus host reaction as cause of erythrophagic splenomegaly in a child?
1977 • 10 citations